1. Summary of safety and effectiveness for On-X 2001 aortic, FDA PMA P000037, May 30, 2001 and March 6, 2002 European Primary Trial Updated May 31, 2003.
2. Summary of safety and effectiveness for On-X 2002 mitral, FDA PMA P000037/S1, May 30, 2001 and March 6, 2002 European Primary Trial Updated May 31, 2003.
3. Körtke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg. 2001;72:44–8.
4. Kinsley RH, Colsen PR, Antunes MJ. Medtronic-Hall replacement in a third-world population group. Thorac Cardiovasc Surg. 1983;31(11):69.
5. Meuris B, Flameng W. Performance of bileaflet heart valve prostheses in a new animal model. In: Presented at the 6th Annual Hilton Head Workshop of prosthetic heart valve. March 6–10, 2002.